1. A pharmaceutical inhalation powder composition comprising an active ingredient and a pharmaceutically acceptable carrier in which the active ingredient is at least partially applied to the carrier and for which the release dose is from about 20% to about 75%. The pharmaceutical composition according to claim 1, characterized in that said composition is characterized by precipitation of the released dose in the range from about 22% to 70%. The pharmaceutical composition according to claim 1, characterized in that said composition is characterized by precipitation of the released dose in the range from 25% to 60%. The pharmaceutical composition according to claim 1, wherein the active ingredient comprises a beta-2 adrenergic receptor agonist, a steroid, an anticholinergic agent, a mucolytic, or combinations thereof. The pharmaceutical composition according to claim 1, characterized in that the active ingredient is selected from the group consisting of salbutamol, salmeterol, formoterol, phenoterol, fluticasone, budesonide, mometasone, beclomethasone, cyclesonide, ambroxol, tiotropium, ipratropium, aclidinium, or combinations thereof. The pharmaceutical composition according to claim 1, wherein the pharmaceutically acceptable carrier is lactose. The pharmaceutical composition according to claim 1, characterized in that the mass ratio of the active ingredient to the carrier is in the range from about 1: 2 to about 1: 500.8. A pharmaceutical powder composition for inhalation containing an active ingredient and a pharmaceutically acceptable carrier, the active ingredient being at least partially applied to the carrier, and the composition is characterized by a dose of finely divided particles1. Фармацевтическая порошковая композиция для ингаляций, содержащая активный ингредиент и фармацевтически приемлемый носитель, в которой активный ингредиент по меньшей мере частично нанесен на носитель, и для которой осаждение высвобождаемой дозы составляет от примерно 20% до приме
